Candesartan and standard chronic heart disease therapy
CANc-CHF14-TIF
Phase 3 small_molecule terminated
Quick answer
Candesartan and standard chronic heart disease therapy for Heart Failure is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Heart Failure
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated